Journal
Cancer immunology research
Publication Date
5-3-2022
Volume
10
Issue
5
First Page
597
Last Page
611
Document Type
Open Access Publication
DOI
10.1158/2326-6066.CIR-21-0129
Rights and Permissions
Salmon AJ, Shavkunov AS, Miao Q, Jarjour NN, Keshari S, Esaulova E, Williams CD, Ward JP, Highsmith AM, Pineda JE, Taneja R, Chen K, Edelson BT, Gubin MM. BHLHE40 Regulates the T-Cell Effector Function Required for Tumor Microenvironment Remodeling and Immune Checkpoint Therapy Efficacy. Cancer Immunol Res. 2022 May 3;10(5):597-611. doi.org/10.1158/2326-6066.CIR-21-0129. This open access article is distributed under Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 International (CC BY-NC-ND).
Recommended Citation
Salmon, Avery J; Shavkunov, Alexander S; Miao, Qi; Jarjour, Nicholas N; Keshari, Sunita; Esaulova, Ekaterina; Williams, Charmelle D; Ward, Jeffrey P; Highsmith, Anna M; Pineda, Josué E; Taneja, Reshma; Chen, Ken; Edelson, Brian T; and Gubin, Matthew M, "BHLHE40 regulates the T-cell effector function required for tumor microenvironment remodeling and immune checkpoint therapy efficacy." Cancer immunology research. 10, 5. 597 - 611. (2022).
https://digitalcommons.wustl.edu/open_access_pubs/11795